Preparation method and application of caffeic acid derivative in dracocephalum moldavica
The invention discloses application of a dibenzo [b, f] oxepin ring compound shown in a formula II or a pharmaceutical salt thereof in preparation of a medicine for up-regulating KLF2 expression. The invention also discloses application of the dibenzo [b, f] oxepin ring compound as shown in the form...
Saved in:
Main Authors | , , , , , , , , , , , |
---|---|
Format | Patent |
Language | Chinese English |
Published |
21.06.2022
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The invention discloses application of a dibenzo [b, f] oxepin ring compound shown in a formula II or a pharmaceutical salt thereof in preparation of a medicine for up-regulating KLF2 expression. The invention also discloses application of the dibenzo [b, f] oxepin ring compound as shown in the formula II or the pharmaceutical salt thereof in preparation of medicaments for treating cardiovascular diseases or resisting inflammation. The inventor performs cardiovascular activity evaluation on the dibenzo [b, f] oxepin ring compound by adopting a KLF2 screening model: KLF2-COS7 cells are taken as experimental subjects, and the dibenzo [b, f] oxepin ring compound or the pharmaceutical salt thereof is found to have the activity of remarkably up-regulating expression of target KLF2 related to atherosclerosis, inflammation resistance and the like for the first time; the compound has a good application prospect in the aspect of treating atherosclerosis related diseases. The invention also discloses a preparation meth |
---|---|
Bibliography: | Application Number: CN202210182432 |